Trial
NCT02302755
TP10 Use in Patients With C3 Glomerulopathy (C3G)
Phase IWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
University of Iowa
Collaborators
—
Condition
Dense Deposit Disease
Intervention
TP10
Why stopped
no recruitment
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2016-10-27